<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04032470</url>
  </required_header>
  <id_info>
    <org_study_id>A4080</org_study_id>
    <nct_id>NCT04032470</nct_id>
  </id_info>
  <brief_title>Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)</brief_title>
  <official_title>Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET):ET Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compile characteristics of real-world outcomes for Boston Scientific Corporation's
      commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the
      applicable Directions for Use, for the treatment of Essential Tremor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compile characteristics of real-world outcomes using Deep Brain Stimulation (DBS) for the
      treatment of Essential Tremor to add to the evidence available for treatment of ET.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2028</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Change in Quality of Life during the study as compared with baseline using the Quality of Life in Essential Tremor Questionnaire (QUEST)</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Change in quality of life over the course of the study using QUEST</description>
  </primary_outcome>
  <other_outcome>
    <measure>Change in tremor scores during the study as compared with baseline as assessed by Fahn-Tolosa- Marin Rating Scale</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Improvement in tremor scores as assessed by Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) during the study as compared with baseline</description>
  </other_outcome>
  <other_outcome>
    <measure>Impression of Change scores during the study using Global Impression of Change</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Impression of Change scores during the study using Global Impression of Change</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Essential Tremor</condition>
  <arm_group>
    <arm_group_label>Essential Tremor</arm_group_label>
    <description>Subjects with Essential Tremor being implanted with Boston Scientific Deep Brain Stimulation Systems</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation Systems (DBS)</intervention_name>
    <description>Subjects receiving DBS implant for treatment of Essential Tremor</description>
    <arm_group_label>Essential Tremor</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with Essential Tremor
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meets criteria established in the locally applicable Directions for Use (DFU) for
             Essential Tremor

          -  Is at least 18 years old

        Exclusion Criteria:

          -  Meets any contraindication in locally applicable Directions for Use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane Keesey</last_name>
    <phone>6619494175</phone>
    <email>Diane.Keesey@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roshini Jain</last_name>
    <phone>6619494350</phone>
    <email>roshini.jain@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Scientific Clinical Research</name>
      <address>
        <city>Valencia</city>
        <state>California</state>
        <zip>91355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boston Scientific</last_name>
      <phone>855-213-9890</phone>
      <email>BSNClinicaltrials@bsci.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 8, 2019</study_first_submitted>
  <study_first_submitted_qc>July 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 25, 2019</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Deep Brain Stimulation</keyword>
  <keyword>Boston Scientific</keyword>
  <keyword>Essential Tremor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

